1 – 5 of 16
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Belimumab concentration measurements using a homologous anti-idiotype immunoassay
(
- Contribution to journal › Article
- 2021
-
Mark
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis : The UPSIDE study protocol
(
- Contribution to journal › Article
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
- 2014
-
Mark
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
(
- Contribution to journal › Article